Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study-Reference-Cited by-同舟云学术

Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study

Published:2018-09 Issue:1 Volume:102 Page:61-70
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Qi Fei,Wang Wei-Hu,He Xiao-Hui,Chen Bo,Gui Lin,Fang Hui,Liu Peng,Wang Shu-Lian,Yang Jian-Liang,Song Yong-Wen,Yang Sheng,Qi Shu-Nan,Zhou Sheng-Yu,Li Ye-Xiong,Dong Mei

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference47 articles.

1. Extranodal natural killer/T-cell lymphoma: We should and we can do more;Ying;Chin Clin Oncol,2015

2. Distribution of lymphoid neoplasms in China: Analysis of 4,638 cases according to the World Health Organization classification;Sun;Am J Clin Pathol,2012

3. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution;Yang;Diagn Pathol,2011

4. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: Analysis from a multicenter study;Yang;Blood,2015

5. Predictors of survival of natural killer/T-cell lymphoma, nasal type, in a non-Asian population: A single cancer centre experience;Vasquez;Ecancermedicalscience,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can the radiation dose be safely reduced in the treatment of nk/T cell lymphoma?;Leukemia & Lymphoma;2024-07-05

2. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades;Chemotherapy;2023-11-20

3. Phase 2 Clinical Trial of Simultaneous Boost Intensity Modulated Radiation Therapy With 3 Dose Gradients in Patients With Stage I-II Nasal Type Natural Killer/T-Cell Lymphoma: Long-Term Outcomes of Survival and Quality of Life;International Journal of Radiation Oncology*Biology*Physics;2023-11

4. Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis;Journal of Hematology;2023-10

5. Treatment of extranodal NK/T-cell lymphoma: From past to future;Frontiers in Immunology;2023-02-07